Robert Patrick Drucker

Journal article Teach Learn Med · 2014 BACKGROUND: Although medical school typically lasts 4 years, little attention has been devoted to the structure of the educational experience that takes place during the final year of medical school. SUMMARY: In this perspectives paper, we outline goals fo ... Full text Link to item Cite

In reply

Journal article Academic Medicine · January 1, 2011 Full text Cite

Engaging students in dedicated research and scholarship during medical school: the long-term experiences at Duke and Stanford.

Journal article Acad Med · March 2010 Featured Publication For more than 40 years, the faculties of Duke University School of Medicine (SOM) and Stanford University SOM have encouraged or required students to engage in scholarship as a way to broaden their education and attract them to careers in academic medicine ... Full text Link to item Cite

Varicella vaccination in a primary care pediatric practice.

Journal article Arch Pediatr Adolesc Med · June 1998 Featured Publication Link to item Cite

Lack of effectiveness of a letter reminder for annual influenza immunization of asthmatic children.

Journal article Pediatr Infect Dis J · December 1997 Featured Publication Full text Link to item Cite

Removing a major barrier to universal hepatitis B immunization in infants.

Journal article Arch Pediatr Adolesc Med · January 1996 Featured Publication Full text Link to item Cite

Maternal acceptance of voluntary human immunodeficiency virus antibody testing during the newborn period with the Guthrie card.

Journal article Pediatr Infect Dis J · May 1995 In order to provide the opportunity for women delivering newborns to have human immunodeficiency virus (HIV) testing we piloted a hospital-based voluntary HIV testing program during the newborn period using the Guthrie card. During the study period 789 wom ... Full text Link to item Cite

A major barrier to universal hepatitis B immunization of infants.

Journal article Arch Pediatr Adolesc Med · May 1994 Featured Publication Full text Link to item Cite

Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.

Journal article J Pediatr · July 1991 Full text Link to item Cite

THE ROLE OF HOSPITAL BASED MICROCOMPUTERS IN A STATEWIDE NEONATAL SCREENING-PROGRAM

Journal article PEDIATRIC RESEARCH · April 1, 1991 Link to item Cite

Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.

Journal article Pediatr Infect Dis J · September 1990 Children younger than 2 years of age with previous invasive Haemophilus influenzae (Hib) type b disease may not develop protective antibodies to antigens of Hib and may be at risk of developing a second episode of Hib disease. Twenty-three children with pr ... Link to item Cite

Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.

Journal article J Pediatr · April 1990 Thirty-five children with symptomatic human immunodeficiency virus infection were enrolled in a 12-week, three-center phase I study of intravenous and oral zidovudine therapy. At enrollment the children ranged in age from 5 months to 13 years, with a media ... Full text Link to item Cite

A poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells.

Journal article Proc Natl Acad Sci U S A · December 1988 High levels of expression of cloned genes have been obtained in mammalian cells by using poxvirus-derived insertion/expression vectors. These vectors employ the cis-acting element (CAE I) that directs the transcription of one of the most strongly expressed ... Full text Link to item Cite

Hepatitis B vaccines in patients with chronic renal failure before dialysis.

Journal article J Infect Dis · February 1988 Hepatitis B remains a significant risk to patients receiving chronic hemodialysis, but no certain method of prevention has been identified. We tested two vaccines, plasma-derived vaccine (40-micrograms dose) and recombinant-derived vaccine (40-micrograms a ... Full text Link to item Cite